The pharma giant announced Tuesday that Mikael Dolsten is leaving his role as chief science officer after more than 15 years. Pfizer is conducting an external search for a replacement, with Dolsten staying on to assist in the months-long process. https://hubs.li/Q02FRZVF0
BioSpace
Internet News
West Des Moines, Iowa 112,149 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
The Federal Trade Commission on Tuesday issued an interim report on the top pharmacy benefit managers, showing that they are generating massive profit at the expense of patients by inflating prescription drug costs. https://hubs.li/Q02FRXMG0 #pharma #finance #biospace
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC | BioSpace
biospace.com
-
Following a disappointing readout last year, uniQure on Tuesday posted promising Phase I/II data for its investigational gene therapy AMT-130 and nabbed the first-ever Regenerative Medicine Advanced Therapy designation from the FDA in Huntington’s disease. https://hubs.li/Q02FRNQ90
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data | BioSpace
biospace.com
-
House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” signed into law by the end of this year, including the #BIOSECURE Act which intends to stop federal contracts with Chinese “companies of concern.” https://hubs.ly/Q02FRvWp0 #pharma #policy #biospace | Office of the Speaker of the United States House of Representatives
House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year | BioSpace
biospace.com
-
Eli Lilly and Company's #Mounjaro outperformed Novo Nordisk's #Ozempic at inducing weight loss in obese or overweight adults, according to an observational study published Monday in JAMA Internal Medicine. https://hubs.li/Q02FPk3x0 #pharma #GLP1 #biospace
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study | BioSpace
-
Roche's eye implant Susvimo for patients with neovascular age-related macular degeneration is re-entering the U.S. market after the FDA approved updates to the components of the product. https://hubs.li/Q02FPjLd0 #pharma #biospace
Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall | BioSpace
biospace.com
-
The White House Biden administration is appealing a 2023 jury decision that declared invalid its patent protections over Gilead Sciences' HIV prevention regimen of Truvada and Descovy. https://hubs.li/Q02FPj-10 #pharma #legal #biospace
US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead | BioSpace
biospace.com
-
At the DIA Global 2024 Conference, Dr. Peter Marks, Director of the Center for Biological Evaluation and Research (CBER) at the FDA, and Lori Ellis (Katz), Head of Insights at BioSpace, discussed the advancements being made to help drive forward drug and medical device development. Watch the full interview: https://lnkd.in/ga_z9spj #pharma #policy #biospace
-
The U.K.-based biotech, Myricx Bio, is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A round co-led by Novo Holdings and with participation from Eli Lilly and Company. https://lnkd.in/gJ-VKekY #pharma #seriesA #biospace
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing | BioSpace
biospace.com
-
GLP-1 receptor agonists could reduce the risk of 10 obesity-associated cancers, such as meningioma, multiple myeloma and colorectal cancer, in type 2 diabetes patients, according to an analysis of electronic health records. https://lnkd.in/gJX7k6W3 #pharma #biospace
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study | BioSpace
biospace.com